Objective:

To investigate the role of gut microbiome alterations and intestinal barrier dysfunction in the severity of Vibrio vulnificus infections in a mouse model of metabolic dysfunction–associated steatotic liver disease (MASLD), emphasizing the connection to infection risk.

Key Findings:

• MASLD mice exhibited more severe liver injury, higher liver enzyme levels, and increased inflammation compared to control mice after V. vulnificus infection, with specific increases in ALT and AST levels.
• Histological analyses revealed increased expression of inflammatory and fibrotic markers in MASLD livers post-infection, indicating advanced liver injury.
• Intestinal barrier function was significantly disrupted in MASLD mice, with reduced tight junction protein expression and increased gut permeability markers, suggesting compromised gut integrity.
• The gut microbiome of MASLD mice showed reduced beneficial bacteria and increased organisms associated with inflammation and mucus degradation, highlighting dysbiosis.
• FMT from healthy microbiomes led to reduced liver injury and inflammation in MASLD mice, suggesting potential therapeutic benefits.

Interpretation:

The study suggests that disruptions in gut microbiome and intestinal barrier integrity may exacerbate the severity of infections in patients with MASLD, highlighting the importance of these factors in assessing infection risk and potential therapeutic interventions.

Limitations:

• Findings are based on an acute mouse model, which may not fully replicate human disease mechanisms, particularly in chronic conditions.
• Further studies are needed to confirm the relevance of these findings in human populations and to explore the underlying biological mechanisms.

Conclusion:

The research underscores the potential role of gut health in liver disease outcomes, suggesting that interventions targeting the gut microbiome could mitigate infection severity in patients with MASLD, with implications for clinical practice.